1 Introduction The privileged status of small-molecule heterocycles in medicinal chemistry arises from their frequent capacity to bind multiple receptors with high affinity, enabling diverse pharmacological outcomes [1, 2]. Analysis of US FDA approvals from 2015 to 2020 revealed that small molecules represented 60% of new molecular entities.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Yabei
Contact Yabei, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack